| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/10/2008 | WO2008040111A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | WO2008040097A1 Furanone compounds and lactam analogues thereof |
| 04/10/2008 | WO2008040059A1 Anti-bacterially active agents and related methods |
| 04/10/2008 | WO2008040043A1 Process for the preparation of pleuromutilins |
| 04/10/2008 | WO2008004128A3 Use of bacterial polysaccharides for biofilm inhibition |
| 04/10/2008 | WO2008002959A3 Hiv integrase inhibitors |
| 04/10/2008 | WO2007142986A3 Aminothiazole derivatives and their uses as antibacterial agents |
| 04/10/2008 | WO2007130785A3 Materials and methods for treating pneumocystis pneumonia |
| 04/10/2008 | WO2007120374A3 Anti-arenaviral compounds |
| 04/10/2008 | WO2007107161A3 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis |
| 04/10/2008 | US20080085918 Fitness assay and associated methods |
| 04/10/2008 | US20080085907 Reverse transcriptase inhibitors; use against HIV with drug resistance to NNRTI's (Non Nucleoside Reverse Transcriptase Inhibitor drugs); Diaryl Pyrrolo(2,3-d)pyrimidines, diaryl purines, diaryl v-triazolo(4,5-d)pyrimidines |
| 04/10/2008 | US20080085904 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant |
| 04/10/2008 | US20080085890 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof |
| 04/10/2008 | US20080085870 Isolated polynucleotides comprising a nucleic acid which operably encodes 50 contiguous amino acids, nucleic acids are fragments of a codon-optimized coding region; a carrier |
| 04/10/2008 | US20080085868 Non-infectious nucleic acid construct encoding a recombinant antibody to that agent; injection of a nucleic acid construct, in the form of a plasmid, encoding a virus-neutralising single chain antibody fragment mediates in vivo expression of antibodies; protecting an animal against exposure to a virus |
| 04/10/2008 | US20080085866 Metallo-desferrioxamine complexes and their use in the treatment of bacterial infections |
| 04/10/2008 | US20080085865 Factor c for treating gram-negative bacterial infection |
| 04/10/2008 | US20080085859 Drug Promoting Ceramide Transport, Base Sequence for Producing the Drug, Method of Measuring Activity of Promoting Ceramide Release and Method of Measuring Activity of Promoting Intermembrane Ceramide Transfer |
| 04/10/2008 | US20080085853 nuclear delivery construct comprises (i) protein H or a fragment or derivative thereof that is capable of being targeted to the nucleus of a eukaryotic cell; |
| 04/10/2008 | US20080085301 Method for transdermal administration of antimicrobial medications |
| 04/10/2008 | US20080085289 An immunogenic composition comprising Staphylococcal poly-N-acetylglucosamine (PNAG) and Type 8 capsular polysaccharide or oligosaccharide from Staph aureus; vaccines; e.g., mixture of a Staph extracellular component binding protein and a staph transporter protein, regulator of virulence or toxin |
| 04/10/2008 | US20080085288 Method of Immunization Against The 4 Dengue Serotypes |
| 04/10/2008 | US20080085282 Methods of detecting and controlling mucoid pseudomonas biofilm production |
| 04/10/2008 | US20080085263 Liquid Depot Formulations |
| 04/10/2008 | US20080085242 modified biodegradable branched chitosans effectively complexed with nucleic acids |
| 04/10/2008 | DE10066235B4 Targeted inhibition of gene expression by administration of double stranded oligoribonucleotide to a cell, useful for treating humans, animals and plants against viral infection |
| 04/10/2008 | CA2665438A1 Carboxamide 4-[(4-pyridyl)amino]pyrimidines useful as hcv inhibitors |
| 04/10/2008 | CA2665351A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | CA2665347A1 Process for the preparation of pleuromutilins |
| 04/10/2008 | CA2665269A1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 04/10/2008 | CA2664396A1 Enantiomerically pure phosphoindoles as hiv inhibitors |
| 04/10/2008 | CA2664236A1 Vaccines against chlamydial infection |
| 04/09/2008 | EP1908839A2 Virulence genes, proteins, and their use |
| 04/09/2008 | EP1908823A1 Component of bromelain |
| 04/09/2008 | EP1908781A2 Modulation of immune response and methods based thereon |
| 04/09/2008 | EP1908780A1 Novel chimeric proteins and methods for using the same |
| 04/09/2008 | EP1908774A1 Antibacterial and antiviral peptides from Actinomadura namibiensis |
| 04/09/2008 | EP1908772A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 04/09/2008 | EP1908770A1 Methods for preparing purified lipopeptides |
| 04/09/2008 | EP1908754A1 Antibiotic maduraphthalazin salts with delayed release of the active substance and their use |
| 04/09/2008 | EP1908750A1 Process for the preparation of pleuromutilins |
| 04/09/2008 | EP1908467A1 Herpesvirus-derived therapeutic agent for pain |
| 04/09/2008 | EP1908449A1 Sterilizer selective to cariogenic bacterium, and method for sterilization of cariogenic bacterium |
| 04/09/2008 | EP1907403A2 Antiviral compounds |
| 04/09/2008 | EP1907389A2 Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
| 04/09/2008 | EP1906998A1 Peptide-based influenza vaccine formulation |
| 04/09/2008 | EP1906997A2 Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| 04/09/2008 | EP1906978A1 Composition for treating skin lesions |
| 04/09/2008 | EP1906970A2 Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores |
| 04/09/2008 | EP1906958A2 Pyrazolo[3,4-b]pyridin-2-yl]-benzoic acid derivatives as hiv integrase inhibitors |
| 04/09/2008 | EP1906954A1 Bicyclic 6-alkylidene-penem b-lactamase inhibitors and -lactam antibiotic combination: a broad spectrum antibiotic |
| 04/09/2008 | EP1906945A2 Hcv inhibitors |
| 04/09/2008 | EP1675605B1 Pharmaceutical composition which can be used, for example, as an antiviral or antibacterial agent and to stimulate immune defences |
| 04/09/2008 | EP1551423B1 Compositions comprising amphotericin B comprising less than 4 % impurities |
| 04/09/2008 | EP1442114B1 Bacterium causing poultry disease and vaccine derived therefrom |
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 04/09/2008 | EP1370247B1 Taste masked pharmaceutical compositions |
| 04/09/2008 | EP1345613B1 Probiotic compounds derived from lactobacillus casei strain ke01 |
| 04/09/2008 | EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials |
| 04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 04/09/2008 | CN101160306A 苯并咪唑化合物 Benzimidazole compounds |
| 04/09/2008 | CN101160294A Anti-cancer and anti-microbial oxazolidinones and analogues |
| 04/09/2008 | CN101160119A Process for the preparation of poly DL-lactide-co-glycolide nanoparticles having antitubercular drugs encapsulated therein |
| 04/09/2008 | CN101157907A Recombinant salmonella choleraesuis strain for expression of pig origin bordetella bronchisepatica fhaB and prn gene segment, bacterin and uses thereof |
| 04/09/2008 | CN101157724A Modified recombinant porcine alpha interferon protein and coding gene and uses thereof |
| 04/09/2008 | CN101157717A Preparation method of Ardisia mamillata B and uses thereof |
| 04/09/2008 | CN101157698A Novel cephalosporin derivant |
| 04/09/2008 | CN101157684A Aspartic acid lomefloxacin hydrate and preparation and uses thereof |
| 04/09/2008 | CN101156939A A medicine for treating tinea manuum |
| 04/09/2008 | CN101156914A Method for extracting triterpenic acid from Chinese date dregs |
| 04/09/2008 | CN101156910A A dysentery stopping traditional Chinese medicine preparation for animals and method for making same as well as quality control method |
| 04/09/2008 | CN101156907A A pueraria root scutellaria and coptis extract |
| 04/09/2008 | CN101156897A A medicine for treating zoster sequela neuralgia |
| 04/09/2008 | CN101156888A A traditional Chinese medicine for treating appendicitis |
| 04/09/2008 | CN101156885A New purpose of honeysuckle leaves in treatment of acquired immuno-deficiency syndrome |
| 04/09/2008 | CN101156873A A white blood cell antibiotic activity substance from siam alligator and method for making same |
| 04/09/2008 | CN101156868A A bacterium-resisting nursing article |
| 04/09/2008 | CN101156864A A roxoithromycin and compound recipe preparation |
| 04/09/2008 | CN101156856A Falacyclovir dispersion piece and its preparation method |
| 04/09/2008 | CN101156835A Preparation method of hypericin oral liquid |
| 04/09/2008 | CN100379865C Method and reagents for vaccination which generate a CD8 T cell immune response |
| 04/09/2008 | CN100379762C Interfusion protein between human serum albumin and interleukin, and encoding genes |
| 04/09/2008 | CN100379759C Compounds for treatment of infectious and immune system disorders and method for their use |
| 04/09/2008 | CN100379758C Streptococcus pneumoniae antigens |
| 04/09/2008 | CN100379750C Inhibitors of nucleoside phosphorylases and nucleosidases |
| 04/09/2008 | CN100379738C Novel B-lactam compounds and process for producing the same |
| 04/09/2008 | CN100379733C Rriazole antifungal agent and method for preparing the same |
| 04/09/2008 | CN100379457C Solubilization method of acyclovir in acyclovir injection liquid |
| 04/09/2008 | CN100379453C Use of myxoma virus for therapeutic treatment of cancer and chronic viral infection |
| 04/09/2008 | CN100379452C Methods and vaccines for providing in ovo protection against turkey rhinotracheitis |
| 04/09/2008 | CN100379451C 疫苗 Vaccine |
| 04/09/2008 | CN100379450C Method of expressing antigen on the surface of an antigen-presenting cell by photochemical internalisation |
| 04/09/2008 | CN100379448C 蛋白酶抑制剂 Protease inhibitors |
| 04/09/2008 | CN100379438C Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation method |
| 04/09/2008 | CN100379434C Medicine for treating manus and pedes tinea and its preparation method |
| 04/09/2008 | CN100379421C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/09/2008 | CN100379417C Application of sophocarpine in use of making medicines |
| 04/09/2008 | CN100379395C Method for covering an open wound, and manufacturing of a wound dressing for covering an open wound |